• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

与抗体介导的肾移植排斥反应相关的HLA特异性抗体的功能和表型特征

Functional and phenotypic profiles of HLA-specific antibodies in relation to antibody-mediated kidney transplant rejection.

作者信息

Carpenter Margaret C, Shrestha Sweta, Bharadwaj Pranay, Concetta Catalano, Sharma Shilpee, Weiner Joshua A, de Haan Noortje, Pongracz Tamas, Le Moine Alain, Holovska Vanda, Marchant Arnaud, Ackerman Margaret E

机构信息

Thayer School of Engineering, Dartmouth College Hanover NH USA.

Department of Microbiology and Immunology, Geisel School of Medicine at Dartmouth, Dartmouth College Hanover NH USA.

出版信息

Hum Immunol. 2025 Mar;86(2):111247. doi: 10.1016/j.humimm.2025.111247. Epub 2025 Jan 30.

DOI:10.1016/j.humimm.2025.111247
PMID:39889319
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11922655/
Abstract

Donor Specific Antibodies (DSAs) are associated with a higher risk of Antibody Mediated Rejection (AMR). However, not all DSAs are pathogenic, and patients that raise DSAs have a wide spectrum of outcomes ranging from the complete absence of graft injury to severe AMR. Hence, characterization of both the qualitative features and titer of DSAs has the potential to predict AMR risk and treatment outcome for sensitized patients. Here, using HLA-A2+ cell-based assays, we investigate the qualitative features of immunoglobulin G (IgG) alloantibodies including Fc receptor binding properties and Fc-mediated effector function over time. Compared to seronegative controls, reactive antibodies in seropositive participants were predominantly IgG1, and exhibited elevated levels of binding to the receptors involved in Antibody Dependent Cellular Phagocytosis (ADCP) and Antibody Dependent Cellular Cytotoxicity (ADCC) activity. Further analysis of seropositive individuals revealed that these activities were predictive ofAMR status. Collectively, these results suggest a role for phagocytic and cytotoxic antibody effector functions of DSA in contributing to graft injury.

摘要

供者特异性抗体(DSA)与抗体介导的排斥反应(AMR)风险较高相关。然而,并非所有DSA都具有致病性,产生DSA的患者有广泛的转归范围,从完全没有移植物损伤到严重的AMR。因此,对DSA的定性特征和滴度进行表征有可能预测致敏患者的AMR风险和治疗结果。在此,我们使用基于HLA - A2 +细胞的检测方法,研究免疫球蛋白G(IgG)同种异体抗体的定性特征,包括随时间推移的Fc受体结合特性和Fc介导的效应器功能。与血清阴性对照相比,血清阳性参与者中的反应性抗体主要为IgG1,并表现出与参与抗体依赖性细胞吞噬作用(ADCP)和抗体依赖性细胞毒性(ADCC)活性的受体结合水平升高。对血清阳性个体的进一步分析表明,这些活性可预测AMR状态。总体而言,这些结果表明DSA的吞噬和细胞毒性抗体效应器功能在导致移植物损伤中起作用。

相似文献

1
Functional and phenotypic profiles of HLA-specific antibodies in relation to antibody-mediated kidney transplant rejection.与抗体介导的肾移植排斥反应相关的HLA特异性抗体的功能和表型特征
Hum Immunol. 2025 Mar;86(2):111247. doi: 10.1016/j.humimm.2025.111247. Epub 2025 Jan 30.
2
Afucosylation of HLA-specific IgG1 as a potential predictor of antibody pathogenicity in kidney transplantation.HLA特异性IgG1的去岩藻糖基化作为肾移植中抗体致病性的潜在预测指标。
Cell Rep Med. 2022 Nov 15;3(11):100818. doi: 10.1016/j.xcrm.2022.100818.
3
Immunoglobulin G subclass analysis of HLA donor specific antibodies in heart and renal transplant recipients.心脏和肾移植受者中HLA供体特异性抗体的免疫球蛋白G亚类分析
Clin Transpl. 2013:413-22.
4
Sialylation of antibodies in kidney recipients with de novo donor specific antibody, with or without antibody mediated rejection.初次产生供体特异性抗体的肾移植受者体内抗体的唾液酸化,伴或不伴有抗体介导的排斥反应。
Hum Immunol. 2016 Nov;77(11):1076-1083. doi: 10.1016/j.humimm.2015.10.021. Epub 2015 Nov 10.
5
Donor-Specific Antibodies in Kidney Transplant Recipients.供者特异性抗体在肾移植受者中的作用。
Clin J Am Soc Nephrol. 2018 Jan 6;13(1):182-192. doi: 10.2215/CJN.00700117. Epub 2017 Apr 26.
6
Determining donor-specific antibody C1q-binding ability improves the prediction of antibody-mediated rejection in human leucocyte antigen-incompatible kidney transplantation.确定供体特异性抗体的C1q结合能力可改善对人类白细胞抗原不相容肾移植中抗体介导排斥反应的预测。
Transpl Int. 2017 Apr;30(4):347-359. doi: 10.1111/tri.12873. Epub 2016 Nov 2.
7
Impact of alloantibody strength in crossmatch negative DSA positive kidney transplantation.交叉配型阴性、直接抗球蛋白试验阳性的肾移植中同种抗体强度的影响。
Clin Biochem. 2013 Oct;46(15):1389-93. doi: 10.1016/j.clinbiochem.2013.05.053. Epub 2013 May 29.
8
Impact of active antibody-mediated rejection treatment on donor-specific antibodies in pediatric kidney transplant recipients.主动抗体介导的排斥反应治疗对小儿肾移植受者供者特异性抗体的影响。
Pediatr Transplant. 2019 Dec;23(8):e13590. doi: 10.1111/petr.13590. Epub 2019 Oct 16.
9
Analysis of preformed donor-specific anti-HLA antibodies characteristics for prediction of antibody-mediated rejection in kidney transplantation.分析预先形成的供者特异性抗人白细胞抗原抗体特征以预测肾移植中的抗体介导排斥反应。
Transpl Immunol. 2015 Mar;32(2):66-71. doi: 10.1016/j.trim.2015.01.002. Epub 2015 Feb 7.
10
Failure to remove de novo donor-specific HLA antibodies is influenced by antibody properties and identifies kidney recipients with late antibody-mediated rejection destined to graft loss - a retrospective study.未能清除新产生的供体特异性 HLA 抗体受抗体特性的影响,并可识别出发生晚期抗体介导排斥反应导致移植物丢失的肾移植受者——一项回顾性研究。
Transpl Int. 2019 Jan;32(1):38-48. doi: 10.1111/tri.13325. Epub 2018 Aug 27.

本文引用的文献

1
The Influence of Human IgG Subclass and Allotype on Complement Activation.人免疫球蛋白亚类和同种异型对补体激活的影响。
J Immunol. 2023 Dec 1;211(11):1725-1735. doi: 10.4049/jimmunol.2300307.
2
Expansion of Anticomplement Therapy Indications from Rare Genetic Disorders to Common Kidney Diseases.从罕见遗传疾病到常见肾脏疾病的抗补体治疗适应证的扩展。
Annu Rev Med. 2024 Jan 29;75:189-204. doi: 10.1146/annurev-med-042921-102405. Epub 2023 Sep 5.
3
Complement is activated by elevated IgG3 hexameric platforms and deposits C4b onto distinct antibody domains.
补体通过升高的 IgG3 六聚体平台被激活,并将 C4b 沉积到不同的抗体结构域上。
Nat Commun. 2023 Jul 7;14(1):4027. doi: 10.1038/s41467-023-39788-5.
4
Subclass-switched anti-spike IgG3 oligoclonal cocktails strongly enhance Fc-mediated opsonization.亚类转换的抗刺突 IgG3 寡克隆鸡尾酒强烈增强 Fc 介导的调理作用。
Proc Natl Acad Sci U S A. 2023 Apr 11;120(15):e2217590120. doi: 10.1073/pnas.2217590120. Epub 2023 Apr 3.
5
Endo-lysosomal assembly variations among human leukocyte antigen class I (HLA class I) allotypes.人类白细胞抗原 I 类(HLA I 类)同种异型之间的内体 - 溶酶体组装变化。
Elife. 2023 Feb 1;12:e79144. doi: 10.7554/eLife.79144.
6
Afucosylation of HLA-specific IgG1 as a potential predictor of antibody pathogenicity in kidney transplantation.HLA特异性IgG1的去岩藻糖基化作为肾移植中抗体致病性的潜在预测指标。
Cell Rep Med. 2022 Nov 15;3(11):100818. doi: 10.1016/j.xcrm.2022.100818.
7
A role for complement blockade in kidney transplantation.补体阻断在肾移植中的作用。
Cell Mol Immunol. 2022 Jul;19(7):755-757. doi: 10.1038/s41423-022-00854-5. Epub 2022 Mar 24.
8
Graft and Patient Survival Rates in Kidney Transplantation, and Their Associated Factors: A Systematic Review and Meta-Analysis.肾移植中的移植物和患者生存率及其相关因素:一项系统评价和荟萃分析
Iran J Public Health. 2021 Aug;50(8):1555-1563. doi: 10.18502/ijph.v50i8.6801.
9
IgG3 donor-specific antibodies with a proinflammatory glycosylation profile may be associated with the risk of antibody-mediated rejection after kidney transplantation.IgG3 供体特异性抗体具有促炎糖基化特征,可能与肾移植后抗体介导的排斥反应风险相关。
Am J Transplant. 2022 Mar;22(3):865-875. doi: 10.1111/ajt.16904. Epub 2021 Dec 18.
10
Imlifidase for the treatment of anti-HLA antibody-mediated processes in kidney transplantation.伊米利法酶用于治疗肾移植中抗人白细胞抗原抗体介导的过程。
Am J Transplant. 2022 Mar;22(3):691-697. doi: 10.1111/ajt.16828. Epub 2021 Sep 13.